Skip to content

Single- Versus Multiple-dose Antimicrobial Prophylaxis for The Prevention of Infectious Complications Associated With Peroral Endoscopic Myotomy(POEM) for Achalasia

Single- Versus Multiple-dose Antimicrobial Prophylaxis for The Prevention of Infectious Complications Associated With Peroral Endoscopic Myotomy(POEM) for Achalasia: A Triple-Blind, Randomized Controlled, Non-Inferiority Trial

Status
UNKNOWN
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03404739
Enrollment
666
Registered
2018-01-19
Start date
2017-10-01
Completion date
2019-01-31
Last updated
2018-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Achalasia

Keywords

Antibiotic prophylaxis, Infectious complications, Peroral endoscopic myotomy

Brief summary

Peroral endoscopic myotomy is a novel, promising endoscopic technique for achalasia considering its minimal invasive characteristics and comparable efficacy to Heller myotomy. Numerous studies have focused on the efficacy, safety as well as technical aspects of POEM. However, few efforts have been made to the issue of antimicrobial prophylaxis in POEM. Postoperative prophylactic antibiotics are universally initiated on call to the operating room or at the start of POEM and consist of second-generation cephalosporins. The mean duration of antibiotic regimen after POEM was 3 days ranging from 1 day to 7 days. Numerous studies have shown that a single dose of antibiotic prophylaxis in a variety of surgical procedures. Other studies have shown that prolonged administration of antibiotics for longer than 24 hours add no benefit in many surgeries. Prolonged use of antibiotics not only increases the costs and exposure to drug toxicity directly but also may be associated with an increased risk of acquired antibiotic resistance as well as infection with Clostridium difficile. Thus, investigators intend to perform a prospective randomized study to confirm the validity of single-dose antimicrobial prophylaxis for the prevention of infectious complications following peroral endoscopic myotomy.

Detailed description

This prospective randomized trial is performed to confirm the noninferiority of single-dose versus multiple-dose antimicrobial prophylaxis in terms of the incidence of infectious complications associated with peroral endoscopic myotomy. Six hundred sixty-six patients undergoing POEM for achalasia will be randomized to receive only single-dose ceftazidime (2g) or an additional 2 doses every 12 hours postoperatively (multi-dose group). POEM associated infectious complications will be assessed and recorded as regional infections, remote infections and systemic infections. Infection rate, adverse events related to antibiotics and POEM, Clavien-Dindo classification of surgical complications, length of hospital stay and efficacy of POEM will be compared. Body fluid bacterial culture will be conducted in patients suspected of infectious complications.

Interventions

DRUGSaline Solution

These patients will be given only one dose of ceftazidime at the start of POEM plus 2 doses of saline solution every 12 hours after the procedure.

DRUGCeftazidime

These patients will be given ceftazidime 2g at the start of POEM plus additional 2 doses given every 12 hours after the procedure.

Sponsors

Shanghai Zhongshan Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Investigator)

Masking description

Sequentially numbered, opaque sealed envelopes(SNOSE) will be the method to conceal allocation from the study team.

Intervention model description

single- versus multiple-dose antimicrobial prophylaxis

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed of esophageal achalasia * Patients or legal surrogates willing and competent to give informed consent and to comply with follow up visits and tests

Exclusion criteria

* Patients with ASA score ≥3 * Patients with indications for antibiotic prophylaxis(infective endocarditis or other conditions) as determined by the American Society for Gastrointestinal Endoscopy * Patients who have received antibiotics in the past seven days * Patients who have possible signs of infection during preparation for POEM * Pregnant * Immunodeficient patients such as severe neutropenia(\<0.5x1068/l) and/or advanced hematological malignancy * Under steroid therapy * Patients who develop intraoperative severe adverse events including severe choking and aspiration during endotracheal intubation requiring antibiotic treatment as well as severe pneumothorax, perforation, bleeding and mucosal injury cannot be closed by clips.

Design outcomes

Primary

MeasureTime frameDescription
Infectious complications associated with POEMFrom operation day to 4 weeks after the procedureIncluding regional, remote and systemic infections.

Secondary

MeasureTime frameDescription
Pathogens for causing infectionFrom operation day to 4 weeks after the procedureBody fluid will be collected and cultured in patients suspected of infectious complications
Adverse effects of antibioticsFrom operation day to 4 weeks after the procedureAny adverse events related to ceftazidime will be recorded.
Clavien-Dindo classification of surgical complicationsFrom operation day to 4 weeks after the procedureClavien-Dindo classification of surgical complications is recorded if adverse events happen related to POEM
Length of hospital stayFrom admission to dischargeLength of hospital stay will be extracted.
Efficacy of POEMadmission to 4 weeks after POEMEckardt score will be compared before and after POEM.Clinical scoring system for achalasia (Eckardt score) Score Symptom Weight loss (kg)(0-3), Dysphagia(0-3), Retrosternal pain(0-3), Regurgitation(0-3)

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026